CryoTherapeutics has developed a patented system consisting of a console and an intracoronary balloon catheter to be used by interventional cardiologists. The Cryotherapy System (CTS) is a lesion-specific, implant-free device designed to cool vulnerable plaque at high risk of rupture in order to stabilize it and potentially prevent major cardiac events in patients with non-flow-limiting Coronary Artery Disease.

Using X-ray guidance, the catheter is advanced until the balloon is positioned at the level of the plaque requiring treatment. The operator inflates the balloon and initiates the cryo-procedure: the console then delivers the cooling agent through the catheter in a controlled manner to cool down the solution inside the balloon, maintaining a temperature between -10°C to -20°C required for the treatment of the vulnerable plaque.

Each catheter is for a single use only whereas the console is reusable.

The console – delivers cryotherapy to the tip of the catheter
The console and cylinder

User interface providing procedure status data to the physician
Connection to the catheter
The catheter
 

Update

CryoTherapeutics closes new €12.3 million financing round.

Find out more